Zynlonta OverviewLoncastuximab tesirine , sold under the brand name Zynlonta, is a monoclonal antibody conjugate medication used to treat large B-cell lymphoma. It is an antibody-drug conjugate (ADC) composed of a humanized antibody targeting the protein CD19. Loncastuximab tesirine was approved for medical use in the United States in April 2021. Contents 1 Medical uses 2 Technology 3 Clinical trials 4 Orphan drug designation 5 Ref...
Read more Zynlonta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loncastuximab_tesirine
Recent Zynlonta Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 10mg